Renoprotective Effect of Tanshinone IIA, An Active Component of Salvia miltiorrhiza, on Rats with Chronic Kidney Disease

被引:73
作者
Ahn, Young-Min [1 ]
Kim, Su Kang [2 ]
Lee, Sang-Hun [1 ]
Ahn, Se-Young [1 ]
Kang, Sung Wook [2 ]
Chung, Joo-Ho [2 ]
Kim, Sung-Do [3 ]
Lee, Byung-Cheol [1 ]
机构
[1] Kyung Hee Univ, Coll Oriental Med, Dept Internal Med, Seoul 130702, South Korea
[2] Kyung Hee Univ, Kohwang Med Res Inst, Seoul 130701, South Korea
[3] Kyung Hee Univ, E W Kidney Dis Res Inst, Dept Pediat, Seoul 130702, South Korea
关键词
Tanshinone IIA; renoprotection; nephrectomy; chronic kidney disease; MESANGIAL CELL-PROLIFERATION; NITRIC-OXIDE SYNTHASE; ANGIOTENSIN-II; EXTRACELLULAR-MATRIX; GROWTH-FACTOR; DIABETIC-NEPHROPATHY; RENAL-DISEASE; IN-VITRO; BIOSYNTHESIS; HYPERTENSION;
D O I
10.1002/ptr.3347
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Chronic kidney disease (CKD) is a common cause of end-stage renal disease. Antihypertensive agents are used clinically to inhibit the progression of CKD, but cannot prevent eventual renal failure. This study investigated the effect of Tanshinone IIA, an active component of Salvia miltiorrhiza, in rats suffering from CKD induced by 5/6 nephrectomy. After development of renal insufficiency, the rats were treated with Tanshinone IIA (10 mg/kg) for 8 weeks. Serum creatinine, angiotensin II (Ang II), transforming growth factor beta 1 (TGF-beta 1) and collagen IV levels were significantly reduced in Tanshinone HA treated rats compared with a control group. In addition, Tanshinone HA suppressed increases in urinary protein excretion in CKD rats. These findings suggest that chronic oral administration of Tanshinone IIA can improve renal dysfunction associated with CKD. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:1886 / 1892
页数:7
相关论文
共 34 条
[1]
ANGIOTENSIN-II CAUSES MESANGIAL CELL HYPERTROPHY [J].
ANDERSON, PW ;
DO, YS ;
HSUEH, WA .
HYPERTENSION, 1993, 21 (01) :29-35
[2]
The burden of kidney disease: Improving global outcomes [J].
Eknoyan, G ;
Lameire, N ;
Barsoum, R ;
Eckardt, KU ;
Levin, A ;
Levin, N ;
Locatelli, F ;
MacLeod, A ;
Vanholder, R ;
Walker, R ;
Wang, HY .
KIDNEY INTERNATIONAL, 2004, 66 (04) :1310-1314
[3]
Effect of angiotensin II receptor blocker on plasma levels of TGF-β1 and interstitial fibrosis in hypertensive kidney transplant patients [J].
El-Agroudy, AE ;
Hassan, NA ;
Foda, MA ;
Ismail, AM ;
El-Sawy, EA ;
Mousa, O ;
Ghoneim, MA .
AMERICAN JOURNAL OF NEPHROLOGY, 2003, 23 (05) :300-306
[4]
Fogo AB, 1999, EXP NEPHROL, V7, P147
[5]
Projecting the number of patients with end-stage renal disease in the United States to the year 2015 [J].
Gilbertson, DT ;
Liu, JN ;
Xue, JL ;
Louis, TA ;
Solid, CA ;
Ebben, JP ;
Collins, AJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (12) :3736-3741
[6]
Jang SI, 2003, PLANTA MED, V69, P1057, DOI 10.1055/s-2003-45157
[7]
Ji ZQ, 2005, CELL MOL IMMUNOL, V2, P150
[8]
RENAL INJURY FROM ANGIOTENSIN-II - MEDIATED HYPERTENSION [J].
JOHNSON, RJ ;
ALPERS, CE ;
YOSHIMURA, A ;
LOMBARDI, D ;
PRITZL, P ;
FLOEGE, J ;
SCHWARTZ, SM .
HYPERTENSION, 1992, 19 (05) :464-474
[9]
Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension [J].
Kim, David D. ;
Sanchez, Fabiola A. ;
Duran, Ricardo G. ;
Kanetaka, Takehito ;
Duran, Walter N. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 292 (05) :H2131-H2137
[10]
Effect of Rehmannia glutinosa on immediate type allergic reaction [J].
Kim, H ;
Lee, E ;
Lee, S ;
Shin, T ;
Kim, Y ;
Kim, J .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1998, 20 (4-5) :231-240